Hobbs M J, Butterworth M, Cohen G M, Upshall D G
Chemical and Biological Defence Establishment, Porton Down, Salisbury, Wiltshire, U.K.
Biochem Pharmacol. 1993 Apr 22;45(8):1605-12. doi: 10.1016/0006-2952(93)90301-c.
Pretreatment with cysteine esters increases cysteine (CySH) levels in rat lung and protects against the lethal effects of inhaled perfluoroisobutene in vivo. There are marked differences in the duration of protection achieved with different cysteine esters. In this study we have compared the uptake and metabolism of CySH, N-acetyl cysteine (NAc), cysteine esters and cystine esters in vitro using rat lung and liver homogenates and lung slices. Liver homogenates metabolized CySH and cysteine esters faster than lung homogenates. The half life (T1/2) of CySH in lung was 58.8 +/- 17.3 min and in liver was 14.0 +/- 1.6 min (mean +/- SEM). T1/2 of the esters in lung ranged between 6.5 and 12.1 min and in liver between 1.9 and 5.3 min. Cysteine tertiary butyl ester, which does not protect in vivo, was not hydrolysed to CySH by lung or liver homogenates. All esters increased and prolonged intracellular CySH concentrations in lung slices to a much greater extent than CySH itself. NAc did not raise intracellular CySH above that of the controls and no NAc appeared within the slice. After CySH incubation intracellular CySH was 0.9 +/- 0.1 nmol/mg wet wt at 10 min whereas after incubation with the esters it ranged between 2.60 and 3.65 nmol/mg wet wt. Cysteine cyclohexyl ester prolonged the increase of CySH the longest and cysteine methyl ester the shortest. CySH levels with cysteine cyclohexyl ester were 2.74 +/- 0.15 and 4.13 +/- 0.37 nmol/mg wet wt at 10 and 60 min, respectively, whereas with cysteine methyl ester, CySH levels were 2.60 +/- 0.5 and 1.25 +/- 0.08 nmol/mg wet wt at similar times. Cystine esters increased intracellular concentrations of both cystine and CySH. CySH concentrations ranged between 2.92 and 3.19 nmol/mg wet wt and cystine between 1.39 and 1.47 nmol/mg wet wt at 60 min. The elevation and duration of CySH in lung slices is well correlated with the duration of protection against perfluoroisobutene achieved in vivo.
用半胱氨酸酯进行预处理可提高大鼠肺中的半胱氨酸(CySH)水平,并在体内保护其免受吸入全氟异丁烯的致死作用。不同的半胱氨酸酯所实现的保护持续时间存在显著差异。在本研究中,我们使用大鼠肺和肝匀浆以及肺切片,在体外比较了CySH、N - 乙酰半胱氨酸(NAc)、半胱氨酸酯和胱氨酸酯的摄取与代谢。肝匀浆比肺匀浆更快地代谢CySH和半胱氨酸酯。CySH在肺中的半衰期(T1/2)为58.8±17.3分钟,在肝中为14.0±1.6分钟(平均值±标准误)。酯类在肺中的T1/2介于6.5至12.1分钟之间,在肝中介于1.9至5.3分钟之间。在体内无保护作用的半胱氨酸叔丁酯,未被肺或肝匀浆水解为CySH。所有酯类比CySH本身在更大程度上提高并延长了肺切片中的细胞内CySH浓度。NAc未使细胞内CySH升高至高于对照组水平,且在切片内未出现NAc。在10分钟时,CySH孵育后细胞内CySH为0.9±0.1 nmol/mg湿重,而与酯类孵育后其范围在2.60至3.65 nmol/mg湿重之间。半胱氨酸环己酯使CySH升高的持续时间最长,半胱氨酸甲酯最短。在10分钟和60分钟时,半胱氨酸环己酯的CySH水平分别为2.74±0.15和4.13±0.37 nmol/mg湿重,而在相似时间,半胱氨酸甲酯的CySH水平为2.60±0.5和1.25±0.08 nmol/mg湿重。胱氨酸酯增加了细胞内胱氨酸和CySH的浓度。在60分钟时,CySH浓度介于2.92至3.19 nmol/mg湿重之间,胱氨酸介于1.39至1.47 nmol/mg湿重之间。肺切片中CySH的升高和持续时间与在体内实现的对全氟异丁烯的保护持续时间密切相关。